Skip to main content
SpringerLink
Log in

Epidemiologie

  • Chapter
Benigne Prostatahyperplasie

  • 60 Accesses

Zusammenfassung

Die benigne Prostatahyperplasie (BPH) ist eine Erkrankung älterer Männer, die sowohl von der Zahl der Betroffenen als auch den Kosten als Volkskrankheit bezeichnet werden kann. Trotzdem sind die Kenntnisse z. B. über den naturlichen Verlauf und die Häufigkeit in den einzelnen Altersgruppen sehr gering. Aus diesem Grund ist in den letzten [ahren eine rege Diskussion über die Indikation für einzelne Therapieverfahren entstanden. Epidemiologische Daten über den Verlauf der Erkrankung sind aus diesem Grunde sowohl für die Prognosestellung als auch die Wahl des richtigen Therapieverfahrens von Bedeutung. Zusätzlich lassen sich sehr viel präziser Normwerte fur einzelne diagnostische Verfahren sowie Symptomscores erstellen. Des weiteren sind diese Informationen hilfreich fär die Planung klinischer Studien. Leider sind in Deutschland nur wenige epidemiologische Daten vorhanden, die eine präzise Schätzung der Zahl der betroffenen Männer zulassen. Aus diesem Grund werden intern ationale Studien herangezogen, die zumindest größenordnungsmäßig einen Anhalt geben, wie viele ältere Männer von einer BPH betroffen sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  1. Abrams P (1995) Symptom questionnaires in epidemiological studies of prostate disease. In: Garrraway M (ed) Epidemiology of prostate disease. Springer Berlin Heidelberg,New York, p 33–41.

    Google Scholar 

  2. Abramson ZH, Gofin J, Abramson JH (1994) Obstructive prostatic symptoms: a Community survey in Jerusalem. Int J Epidemiol 23: 797–804

    PubMed  CAS  Google Scholar 

  3. Almer FM, Altwein JE (1994 ) Transurethrale Prostataresektion: Steht ein Wandel in der Therapie der benignen Prostatahyperplasie bevor? Akt Urol 25:143–153

    Google Scholar 

  4. Andersen TF, Bronnum-Hansen H, Sejr T, Roepstorff C (1990) Elevated mortality following transurethral resection of the prostate for benigne hypertrophie! But why? Med Care 28: 870–881

    PubMed  CAS  Google Scholar 

  5. Araki H, Watanabe H, Mishina T, Nakao M (1983) High risk groups for benign prostatic hypertrophy. Prostate 4:253–264

    PubMed  CAS  Google Scholar 

  6. Arrighi HM, Guess HA, Metter EJ, Fozard JL (1990) Symptoms and signs of prostatism as risk factors for prostatectomy. Prostate 16: 253–261

    PubMed  CAS  Google Scholar 

  7. Arrighi HM, Metter EJ, Guess HA, Fozzard JL (1991) Natural history of benign prostatic hyperplasia and risk of prostatectomy: The Baltimore Longitudinal Study of Aging. Urology 38 [Suppl 1]: 4–8

    PubMed  CAS  Google Scholar 

  8. Ashley DJ (1966) Observations of the epidemiology of prostatic hyperplasia in Wales. Br J Urol 38: 567–569

    PubMed  CAS  Google Scholar 

  9. Ashley JSA, Howlett A, Morris JN (1971) Case-fatality of hyperplasia of the prostate in two teaching and three regional-board hospitals. Lancet II: 1308–1311

    Google Scholar 

  10. Asplund R, Aberg HE (1992) Micturation habits of older people. Scand J Urol Nephrol 26: 345–349

    PubMed  CAS  Google Scholar 

  11. Ball AJ, Feneley RCL, Abrams PH (1981) The natural history of untreated »prostatism«. Br J Urol 53:613–616

    PubMed  CAS  Google Scholar 

  12. Ball AJ, Powell PH (1982) Prostatectomy trends in the Bristol area. Br J Urol 54: 539–541

    PubMed  CAS  Google Scholar 

  13. Barham CP, Pocock RD, James ED (1993) Who needs a prostatectomy? Review of a waiting list. Br JUrol 72:314–317

    CAS  Google Scholar 

  14. Barnes BA, O’Brien E, Comstock C, D’Arpa D, Donhahue CL (1985) Report on Variation in rates of utilization of surgical services in the Commonwealth of Massachusetts. J Am Med Assoc 254: 371–375

    CAS  Google Scholar 

  15. Barry MJ (1990) Epidemiololgy and natural history of benign prostatic hyperplasia. Urol Clin North Am 17: 495–507

    PubMed  CAS  Google Scholar 

  16. Barry MJ (1995) Natural history of untreated benign prostatic hyperplasia. In: Garraway M (ed) Epidemiology of prostate disease. Springer Berlin Heidelberg, New York, p 132–44

    Google Scholar 

  17. Barry MJ (1995) Using repeated measures of Symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. J Urol 153:99–103

    PubMed  CAS  Google Scholar 

  18. Barry MJ, O’LearyMP(1995) The development and clinical Utility of symptom scores. Urol Clin North Am 22: 299–307

    PubMed  CAS  Google Scholar 

  19. Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK (1992) The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 148: 1549–1557

    PubMed  CAS  Google Scholar 

  20. Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK (1995) Measuring disease-specific health status in men with benign prostatic hyperplasia. Med Care 33: AS145–AS155

    PubMed  CAS  Google Scholar 

  21. Barry MJ, Williford WO, Chang Y, Machi M, Jones KM, Walker-Corkery R, Lepor H (1995) Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association Symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 154:1770–1774

    PubMed  CAS  Google Scholar 

  22. Batista JE, Regalado R, Arano P, Vicente J (1995) Quality of life, voiding symptoms and uroflowmetry in healthy males and benign prostatic hyperplasia (BPH) patients. J Urol Paris 101: 3–6

    PubMed  CAS  Google Scholar 

  23. Beier-Holgersen R, Bruun J (1990) Voiding pattern of men 60 to 70 years old: population study in an urban population. J Urol 143: 531–532

    PubMed  CAS  Google Scholar 

  24. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479

    PubMed  CAS  Google Scholar 

  25. Birch NC (1988) Serial residual urine volumes in men with prostatic hypertrophy. Br J Urol 62: 571–575

    PubMed  CAS  Google Scholar 

  26. Birkhoff JD, Wiederhorn AR, Hamilton ML, Zinsser HH (1976) Natural history of benign prostatic hypertrophy and acute urinary retention. Urology 7:48–52

    PubMed  CAS  Google Scholar 

  27. Bishop MC (1990) The dangers of a long urological waiting list. Br J Urol 65:433–440

    PubMed  CAS  Google Scholar 

  28. Black N, Glickman ME, Ding J, Flood AB (1995) International Variation in intervention rates -what are the implication for patient selection? Int J Technol Assess Health Care 11: 719–732

    PubMed  CAS  Google Scholar 

  29. Blom JHM (1992) Epidemiologie und natürlicher Verlauf der benignen Prostatahyerplasie (BPH). Urologe A 31:129–134

    PubMed  CAS  Google Scholar 

  30. Bonde HV, Sejr T, Erdmann L et al. (1996) Residual urine in 75-year-old men and women - a normative population study. Scand J Urol Nephrol 30: 89–91

    PubMed  CAS  Google Scholar 

  31. Bosch JL, Hop WC, Kirkels WJ, Schröder FH (1995) The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 75: 622–630

    PubMed  CAS  Google Scholar 

  32. Bosch JLHR, Hop WCJ, Kirkels WJ, Schröder FH(1995) Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the Community. Urology 46 [Suppl 3 A]: 34–40.

    PubMed  CAS  Google Scholar 

  33. Bourke JB, Griffin JP (1966) Hypertension, diabetes mellitus, and blood groups in benign prostatic hypertrophy. Br J Urol 18-23

    Google Scholar 

  34. Bourke JB, Griffin JP (1968) Diabetes mellitus in patients with benign prostatic hyperplasia. Br Med J 4:492–493

    PubMed  CAS  Google Scholar 

  35. Boyle P (1994) Epidemiology of benign prostatic hyperplasia: risk factors and concomitance with hypertension. Br J Clin Pract 74 (Symp Suppl): 18–22

    Google Scholar 

  36. Boyle P (1994) New insights into the epidemiology and natural history of benign prostatic hyperplasia. Prog Clin Biol Res 386: 3–18

    PubMed  CAS  Google Scholar 

  37. Boyle P, McGinn R, Maisonneuve P, La Vecchia C (1991) Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed. Eur Urol 20 [Suppl 2]: 3–10.

    Google Scholar 

  38. Boyle P, Maisonneuve P, Steg A (1996) Decrease in mortality from bengin prostatic hyperplasia: a major unheralded health triumph. J Urol 155:176–180

    PubMed  CAS  Google Scholar 

  39. Breum L, Munck LK, Nielsen RH, Nordestgaard AG (1982) Significance of acute urinary retention due to infravesical obstruction. Scand J Urol Nephrol 16:21–24

    PubMed  CAS  Google Scholar 

  40. Britton JP, Dowell AC, Whelan P (1990) Prevalence of urinary symtoms in men aged over 60. Br J Urol 66:175–176

    PubMed  CAS  Google Scholar 

  41. Chapple CR, Smith D (1994) The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br J Urol 73:117–123

    PubMed  CAS  Google Scholar 

  42. Chisholm GD, Ng PEP, Prescott S (1994) Benign prostatic hyperplasia: the incidence of prostatectomy within and without Europe. Prog Clin Biol Res 386: 345–356

    PubMed  CAS  Google Scholar 

  43. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM (1993) The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150: 85–89

    PubMed  CAS  Google Scholar 

  44. Chyou PH, Nomura MY, Stemmermann GN, Hankin JH (1993) A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate 22:253–264

    PubMed  CAS  Google Scholar 

  45. Clarke R (1937) The prostate and the endocrines. Br J Urol 9:254–271

    Google Scholar 

  46. Clements RC, Griffiths GJ, Peeling WB, Roberts EE, Evans KT (1988) How accurate is the index finger? A comparison of digital and ultrasound examination of the prostatic nodule. Clin Radiol 39: 87–89

    PubMed  CAS  Google Scholar 

  47. Clements R, Griffiths GJ, Peeling WB (1991) »State of the art« transrectal ultrasound imaging in the assessment of prostatic disease. Br J Radiol 64:193–200

    PubMed  CAS  Google Scholar 

  48. Collins GN (1995) The role of transrectal ultrasound in epidemiological studies. In: Garraway M (ed) Epidemiology of prostate disease. Springer Berlin Heidelberg, New York, p 52–63.

    Google Scholar 

  49. Craigen AA, Hickling JB, Saunders CRG, Carpenter RG (1969) Natural history of prostatic obstruction. JR Coli Gen Pract 18: 226–232

    CAS  Google Scholar 

  50. Daniell HW (1993) Larger prostatic adenomas in obese men with no associated increase in obstructive uropathy. J Urol 149:315–317

    PubMed  CAS  Google Scholar 

  51. Department of Veterans Affairs Cooperative Study of TURP for BPH (1993) Comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. J Urol 150:1696–1700

    Google Scholar 

  52. Diokno AC, Brown MB, Goldstein N, Herzog AR (1992) Epidemiology of bladder emptying symptoms in elderly men. J Urol 148:1817–1821

    PubMed  CAS  Google Scholar 

  53. Diokno AC, Brown MB, Goldstein NG, Herzog AR (1994) Urinary flow rates and voiding pressures in elderly men living in a Community. J Urol 151:1550–1553

    PubMed  CAS  Google Scholar 

  54. Eckerlund I, Hakansson S (1989) Variations in resource utilization - the role of medical practice and its economic impact. Soc Sei Med 28:165–173

    CAS  Google Scholar 

  55. Effert P, Ackermann R (1992) Klinische Manifestation und Indikation zur Therapie der benignen Prostatahyperplasie. Urologe A 31:135–141

    PubMed  CAS  Google Scholar 

  56. El Din KE, Koch WFRM, de Wildt MJAM, Kiemeney LALM, Debruyne FMJ, de la Rosette JJMCH (1996) Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostatic hyperplasia. J Urol 155:1959–1964

    PubMed  Google Scholar 

  57. Epstein RS (1991) Age-related differences in risk factors for prostatectomy for BPH: the VA normative aging study. Urology 38 [Suppl 1]: 9–12

    PubMed  CAS  Google Scholar 

  58. Epstein RS, Deverka PA, Chute CG, Panser L, Oesterling JE, Lieber MM, Schwartz S, Patrick D (1992) Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol 45:1431–1445

    PubMed  CAS  Google Scholar 

  59. Feneley MR, Dunsmuir WD, Pearce J, Kirby RS (1996) Reproducibility of uroflow measurement: experience during a duoble-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia. Urology 47: 658–663

    PubMed  CAS  Google Scholar 

  60. Fernandez E, Porta M, Alonso J, AntKirby RS (1996) Reproducibility of uroflow measurement: experience during a duoble-blind, placebo-contröl.

    Google Scholar 

  61. Fischer ES, Malenka DJ, Wennberg JE, Roos NP (1990) Technology assessment using insurance claims. Example of prostatectomy. Int J Technol Assess Health Care 6:194–202

    Google Scholar 

  62. Gardner LB (1993) Geographie variations in priostatectomy rates: the impact of variations in case rates and at-risk surgery rates. Rockville, MD: AHCPR

    Google Scholar 

  63. Garraway WM, Armstrong WM, Auld S, King D, Simpson RJ (1993) Follow-up of a cohort of men with untreated benign prostatic hyperplasia. Eur Urol 24: 313–318

    PubMed  CAS  Google Scholar 

  64. Garraway WM, Collins GN, Lee RJ (1991) High prevalence of benign prostatic hypertrophy in the Community. Lancet 338:469–471

    PubMed  CAS  Google Scholar 

  65. Garraway WM, Russell EBAW, Lee RJ et al. (1993) Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract 43: 318–321

    PubMed  CAS  Google Scholar 

  66. Gilpin SA, Gosling JA, Barnard RJ (1985) Morphological and morphometric studies of the human obstruete, trabeculated urinary bladder. Br J Urol 57: 525–529

    PubMed  CAS  Google Scholar 

  67. Giovannucci E, Rimm EB, Chute CG, Kwachi I, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity and benign prostatic hyperplasia. Am J Epidemiol 140: 989–1002

    PubMed  CAS  Google Scholar 

  68. Girman CJ (1994) Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected Community men. Urology 44: 825–831

    PubMed  CAS  Google Scholar 

  69. Girman CJ, Panser LA, Chute CG et al. (1993) Natural history of prostatism: urinary flow rates in a community-based study. J Urol 150: 887–892

    PubMed  CAS  Google Scholar 

  70. Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, Lieber MM (1995) Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 153:1510–1515

    PubMed  CAS  Google Scholar 

  71. Glynn RJ, Campion EW, Bouchard GR, Silbert JE (1985) The development of benign prostatic hyperplasia among volunteers in the normative aging study. Am J Epidemiol 121: 78–90

    PubMed  CAS  Google Scholar 

  72. Golomb J, Lindner A, Siegel Y, Korczak D (1992) Variability and circadian changes in home uroflowmetry in patients with BPH compared to normal controls. J Urol 147:1044–1047

    PubMed  CAS  Google Scholar 

  73. Graham AG (1977) Scottish prostates: a 6-year review. Br J Urol 49: 679–682

    PubMed  CAS  Google Scholar 

  74. Graversen PH, Gasser TC, Wasson JH, Hinman F, Bruskewitz RC (1989) Controversies about indications for transurethral resection of the prostate. J Urol. 14: 475–481

    Google Scholar 

  75. Grayhack JT (1992) Benign prostatic hyperplasia - the scope of the problem. Cancer 70: 275–279

    PubMed  CAS  Google Scholar 

  76. Guess HA (1994) The natural history of benign prostatic hyperplasia: implications for patient care and clinical trial design. Eur Urol 25 [Suppl 1]: 10–14

    PubMed  Google Scholar 

  77. Guess HA (1995) Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 22: 247–261

    PubMed  CAS  Google Scholar 

  78. Guess HA (1996) Population-based studies of benign prostatic hyperplasia. In: Kirby R, McConnell J, Fitzpatrick J, Roehrborn C, Boyle P (eds) Textbook of benign prostatic hyperplasia. Isis, Oxford, pp 117–124

    Google Scholar 

  79. Guess HA (1996) Measuring disease-specific quality of life in men with benign prostatic hyperplasia. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven, Philadelphia, pp 945–952

    Google Scholar 

  80. Guess HA, Arrighi HM, Metter EJ, Fozard JL (1990) Cumulative prevalence of prostatism matches the autopsy prevalence of BPH. Prostate 17: 241–246

    PubMed  CAS  Google Scholar 

  81. Guess HA, Chute CG, Garraway WM et al. (1993) Similar levels of urological symptoms have similar impact on Scottish and American men - although Scots report less symptoms. J Urol 150: 1701–1706 20 L. Pientka

    Google Scholar 

  82. Guess HA, Jacobsen SJ, Girman C, Oesterling JE, Chute CG, Panser LA, Lieber MM (1995) The role of community-based longitudinal studies in evaluating treatment effects example: benign prostatic hyperplasia. Med Care 33 [Suppl]: AS26–AS35

    PubMed  CAS  Google Scholar 

  83. Guess HM (1992) Benign prostatic hyperplasia: antecedents and natural history. Epidemiol Rev 14:131–153

    PubMed  CAS  Google Scholar 

  84. Hansen MV, Zdanowski A, Spangberg A (1994) Prostatism symptoms in a randomly selected population: introduction of a patient administered population based symptoms evaluation score. Scand J Urol Nephrol 28:371–378

    PubMed  CAS  Google Scholar 

  85. Hastie KJ, Dickinson AJ, Ahmad R, Moisey CU (1990) Acute retention of urine: is trial without catheter justified? JR Coli Surg Edinb 35:225–227

    CAS  Google Scholar 

  86. Herbison AE, Fraundorfer MR, Walton JK (1988) Association between symptomatology and uroflowmetry in benign prostatic hypertrophy. Br J Urol 62:427–430

    PubMed  CAS  Google Scholar 

  87. Heyns CF, Hargreave TB, Redpath AD, Kendrick SW, Clarke JA (1995) Changing patterns of prostatectomy in Scotland: 1971-1989. Eur Urol 27:99–103

    PubMed  CAS  Google Scholar 

  88. Hines JEW (1996) Symptom indices in bladder outlet obstruction. Br J Urol 77:494–501

    PubMed  CAS  Google Scholar 

  89. Hough DM, List A (1991) Reliability of transabdominal ultrasound in the measurement of prostate size. Australas Radiol 35: 358–360

    PubMed  CAS  Google Scholar 

  90. Hunter DJW (1994) Urinary symptoms: prevalence and severity in british men aged 55 and over. J Epidemiol Community Health 48: 569–575

    PubMed  CAS  Google Scholar 

  91. Hunter DJW, Berra-Unamuno A, Martin-Gordo A (1996) Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 155:1965–1970

    PubMed  CAS  Google Scholar 

  92. Hunter DJW, McKee CM, Sanderson CFB, Black NA (1994) Appropriate indications for prostatectomy in the UK - results of a consensus panel. J Epidemiol Community Health 48:58–64

    PubMed  CAS  Google Scholar 

  93. Hunter DJW, McKee CM, Black NA, Sanderson CFB (1995) Health care sought and received by men with urinary symptoms and their views on prostatectomy. Br J Gen Pract 45:27–30

    PubMed  CAS  Google Scholar 

  94. Hunter DJW, McKee CM, Black NA, Sanderson CFB (1995) The impact of lower urinary tract symptoms on general health status and on the use of prostatectomy. Qual Life Res 4: 335–341

    PubMed  CAS  Google Scholar 

  95. Hunter DJW, McKee M, Black NA, Sanderson CFB (1995) Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology 45: 962–971

    PubMed  CAS  Google Scholar 

  96. Hvidt V, Eldrup J (1994) Comparison of patients undergoing transurethral resection of the prostate in 1935-1936 and 1991-1992. Scand J Urol Nephrol [Suppl 157]: 129–132.

    Google Scholar 

  97. Isaacs JT (1990) Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic Intervention. Prostate [Suppl 3]: 1–7.

    Google Scholar 

  98. Jacobsen SJ (1995) Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men? Urology 45:64–69

    PubMed  CAS  Google Scholar 

  99. Jacobsen SJ, Guess HA, Panser L, Girman CJ, Chute CG, Oesterling JE, Lieber MM (1993) A population-based study of health care-seeking behavior for treatment of urinary symptoms. Arch Fam Med 2: 729–735

    PubMed  CAS  Google Scholar 

  100. Jacobsen SJ, Girman CJ, Guess HA, Panser LA, Chute CG, Oesterling JE, Lieber MM (1993) Natural history of prostatism: factors associated with discordance between frequency and bother of urinary symptoms. Urology 42: 663–671

    PubMed  CAS  Google Scholar 

  101. Jacobsen SJ, Girman CJ, Guess HA, Oesterling JE, Lieber MM (1995) New diagnostic and treatment guidelines for benign prostatic hyperplasia. Arch Intern Med 155:477–481

    PubMed  CAS  Google Scholar 

  102. Jacobsen SJ, Girman CJ, Guess HA, Rhodes T, Oesterling JE, Lieber MM (1996). Natural history of prostatism: longitudinal changes in voiding symptoms in Community dwelling men. J Urol 155: 595–600

    PubMed  CAS  Google Scholar 

  103. Janin P, Haillot O, Boutin JM, Lesourd B, Hubert B, Lanson Y (1995) The frequency of surgery of benign prostatic hypertrophy. Prog Urol 5: 515–521

    PubMed  CAS  Google Scholar 

  104. Jensen KME (1995) Uroflowmetry in elderly men. World J Urol 13:21–23

    PubMed  CAS  Google Scholar 

  105. Jensen KME (1995) Uroflowmetry in epidemiologica studies of prostate disease: some critical considerations. In: Garraway M (ed) Epidemiology of prostate disease. Springer Berlin Heidelberg New York, pp 42–51

    Google Scholar 

  106. Jensen KME, Jorgensen JB, Mogensen P (1988) Urodynamics in prostatism. I Prognostic value of uroflowmetry. Scand J Urol Nephrol 22:109–117

    PubMed  CAS  Google Scholar 

  107. Jolleys JV, Donovan JL, Nanchahal K, Peters TJ, Abrams P (1994) Urinary symptoms in the Community: how bothersome are they? Br J Urol 74:551–555

    PubMed  CAS  Google Scholar 

  108. Jonler M, Wasson JH, Red DJ, Bruskewitz RC (1993). Analysis of watchful waiting studies. In: Kurth K, Newling DWWBenign prostatic hyperplasia. Recent Progress in Clinical Research and Practice. Wiley, New York, 291 –302

    Google Scholar 

  109. Jorgensen JB (1995) Clinical evaluation of voiding symptoms and uroflowmetry in elderly men. Dan Med Bull 42:244–256

    Google Scholar 

  110. Jorgensen JB, Jensen KME (1996) Uroflowmetry. Urol Clin North Am 23:237–242

    PubMed  CAS  Google Scholar 

  111. Jorgensen JB, Jensen KME, Mogensen P (1993) Longitudinal observations on normal and abnormal voiding in men over the age of 50 years. Br J Urol 72:413–420

    PubMed  CAS  Google Scholar 

  112. Jorgensen JB, Jensen KME, Mogensen P (1994) Long-term probality of prostatism vs general morbidity and mortality. Scand J Urol Nephrol 28:163–169

    PubMed  CAS  Google Scholar 

  113. Kadow C, Gingell JC, Penry JB (1985) Prostatic ultrasonography. Br J Urol 57:440–443

    PubMed  CAS  Google Scholar 

  114. Kadow C, Feneley RCL, Abrams PH (1988) Prostatectomy or conservative management in the treatment of benign prostatic hypertrophy? Br J Urol 61: 432–434

    PubMed  CAS  Google Scholar 

  115. Kaplan SA, Te AE (1995) Uroflowmetry and urodynamics. Urol Clin North Am 22: 309–320

    PubMed  CAS  Google Scholar 

  116. Kaplan SA, Bowers DL, Te AE, Olsson CA (1996) Differential diagnosis of prostatism: a 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy. J Urol 155: 1305–1308

    PubMed  CAS  Google Scholar 

  117. Kliewer EV (1996) Benign prostatic hyperplasia morbidity and mortality among immigrants in Australia and Cananda. Prostate 28: 211–218

    PubMed  CAS  Google Scholar 

  118. Koch WFRM, Ezzeldin K, de Wildt MJAM, Debruyne FMJ, de la Rosette JJMCH (1996) The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. J Urol 155:186–189

    PubMed  CAS  Google Scholar 

  119. La Vecchia C, Levi F, Lucchini F (1995) Mortality from benign prostatic hyperplasia: worldwide trends 1950-1992. J Epidemiol Community Health 49: 379–384

    PubMed  Google Scholar 

  120. Lawrence K (1996) Measurement properties of the AUA Symptom score: a methodological clarification. Br J Urol 77/2:175–180

    Google Scholar 

  121. Lee AJ, Rüssel EBAW, Garraway WM, Prescott RJ(1996) Three-year follow-up of a communitybased cohort of men with untreated benign prostatic hyperplasia. Eur Urol 30/1:11–17

    Google Scholar 

  122. Lepor H, Machi G (1993) Comparison of AUA Symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 42: 36–41

    PubMed  CAS  Google Scholar 

  123. Lloyd SN, Kirk D (1991) Who should have a prostatectomy? A survey of the management of patients presenting with bladder outflow obstruction. JR Soc Med 84: 533–535

    CAS  Google Scholar 

  124. Lu-Yao GL, Barry MJ, Chang CH, Wasson JH, Wennberg JE (1994) Transurethral resection of the prostate among medicare beneficiaries in the United States: time trends and outcomes. Urology 44:692–699

    PubMed  CAS  Google Scholar 

  125. Lytton B, Emery JM, Harvard BM (1968) The incidence of benign prostatic obstruction. J Urol 99:639–645

    PubMed  CAS  Google Scholar 

  126. Macfarlane GJ, Sagnier PP, Richard F, Teillac P, Botto H, Boyle P (1995) Determinants of treatment-seeking behaviour for urinary symptoms in older men. Br J Urol 76: 714–718

    PubMed  CAS  Google Scholar 

  127. Madsen FA, Bruskewitz RC (1995) Clinical manifestations of benign prostatic hyperplasia. Urol Clin North Am 22: 291–298

    PubMed  CAS  Google Scholar 

  128. Madson FA, Bruskewitz RC (1996) Watchful waiting. In: Kirby R, McConnell J, Fitzpatrick J, Roehrborn C, Boyle P (eds) Textbook of benign prostatic hyperplasia. ISIS, Oxford, pp 233–238

    Google Scholar 

  129. Matzkin H, Soloway MS (1993) Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and prostate cancer. Prostate 22: 277–290

    PubMed  CAS  Google Scholar 

  130. Matzkin H, Cytron S, Simon D (1996) Is there an association between cigarette smoking and gland size in benign prostatic hyperplasia? Prostate 29:42–45

    PubMed  CAS  Google Scholar 

  131. Matzkin H, Greenstein A, Pragergeller T, Shabtai E, Sofer M, Braf Z (1996) Do reported micturition symptoms on the american urological association questionnaire correlate with 24-hour home uroflowmetry recordings? J Urol 155:197–199

    PubMed  CAS  Google Scholar 

  132. McConnell JD (1995) Benign prostatic hyperplasia: treatment guidelines and patient Classification. Br J Urol 76: 29–46

    PubMed  Google Scholar 

  133. Mclntosh IB, Power KG, Simpson RJ (1994) Psychological effects of an epidemiological study of benign prostatic hypertrophy. Br J Clin Pract 48:118–121

    Google Scholar 

  134. McPherson, Wennberg JE et al. (1982) Small-area variations in the use of common surgical procedures: an international comparison of new England, England and Norway. N Engl J Med 307: 1310–1314

    Google Scholar 

  135. Meigs JB, Barry MJ (1996) Natural history of benign prostatic hyperplasia. In: Kirby R, McConnell J, Fitzpatrick J, Roehrborn C, Boyle P (eds) Textbook of benign prostatic hyperplasia. ISIS, Oxford, pp 125–138

    Google Scholar 

  136. Meikle AW, Stephenson RA, McWhorter WP, Skolnick MH, Middleton RG (1995) Effects of age, sex steroids, and family relationships on volumes of prostate zones in men with and without prostate cancer. Prostate 26: 253–259

    PubMed  CAS  Google Scholar 

  137. Meyhoff HH, Haid T (1978) Are doctors able to assess prostatic size? Scand J Urol Nephrol 12: 219–221

    PubMed  CAS  Google Scholar 

  138. Milamed DR, Hedley-Whyte J (1994) Contributions of the surgical sciences to a reduction of the mortality rate in the United States for the period 1968 to 1988. Ann Surg 219: 94–102

    PubMed  CAS  Google Scholar 

  139. Miller A (1995) When is prostatectomy indicated? Brit J Surg 52: 744–745

    Google Scholar 

  140. Mobb GE, Pugh F, Peeling B (1994) How long is your waiting list? Experience of a urological waiting list initiative. JR Soc Med 87:140–142

    CAS  Google Scholar 

  141. Morgan C jr, Spruell S (1983) Increased trends of prostate Operations in Alabama. J Med Assoc State Ala 52:17–20

    PubMed  Google Scholar 

  142. Morris GE, Täte JJ, Leach RD (1985) The changing trend in prostatectomy in a district general hospital. Ann R Coli Surg Engl 67: 361–362

    CAS  Google Scholar 

  143. Morrison AS (1978) Prostatic hypertrophy in greater Boston. J Chronic Dis 31: 357–362

    PubMed  CAS  Google Scholar 

  144. Morrison AS (1992) Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 135: 974–980

    PubMed  CAS  Google Scholar 

  145. Mukamel E, Nissenkorn I, Boner G, Servadio C (1979) Occult progressive renal damage in the elderly male due to benign prostatic hypertrophy. J Am Geriatr Soc 27:403–406

    PubMed  CAS  Google Scholar 

  146. Murray K, Massey A, Feneley RCL (1984) Acute urinary retention - a urodynamic assessment. Br J Urol 56:468–473

    PubMed  CAS  Google Scholar 

  147. Nacey JN, Morum P, Delahunt B (1995) Analysis of the prevalence of voiding symptoms in Maori, Pacific Island and Caucasian New Zealand men. Urology 46: 506–511

    PubMed  CAS  Google Scholar 

  148. Napalkov P, Maisonneuve P, Boyle P (1995) Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia. Urology 46 [Suppl 3 A]: 41–46

    PubMed  CAS  Google Scholar 

  149. Neal DE (1990) Irreversible renal failure in men with outflow obstruction: is it a preventable disease? Postgrad Med J 66: 996–999

    PubMed  CAS  Google Scholar 

  150. Norman RW, Nickel JC, Fish D, Pickett SN (1994) »Prostate-related symptoms« in Canadian men 50 years of age or older: prevalence and relationship among symptoms. Br J Urol 74: 542–550

    PubMed  CAS  Google Scholar 

  151. O’Leary MP (1995) Epidemiology of benign prostatic hyperplasia. Br J Urol 76 [Suppl 1]: 1–3

    PubMed  Google Scholar 

  152. Oesterling JE (1990) Benign prostatic hyperplasia. Its natural history, epidemiologic characteristics, and surgical treatment. Arch Fam Med 1: 257–266

    Google Scholar 

  153. Oesterling JE (1991) The origin and development of benign prostatic hyperplasia. An agedependent process. J Androl 12: 348–355

    PubMed  CAS  Google Scholar 

  154. Oesterling JE (1996) Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate [Suppl 6]: 67–73

    Google Scholar 

  155. Panser LA, Chute CG, Girman CJ, Guess HA, Oesterling JE, Lieber MM, Jacobsen SJ (1994) Effect of several recruitment strategies on response rates at baseline in a prospective cohort investigation. The Olmsted County Study of urinary symptoms and health status among men. Ann Epidemiol 4: 321–326

    PubMed  CAS  Google Scholar 

  156. Panser LA, Chute CG, Guess HA et al. (1994) The natural history of prostatism: the effects of non-response bias. Int J Epidemiol 23:1198–1204

    PubMed  CAS  Google Scholar 

  157. Partin AW, Page WF, Lee BR, Sanda MG, Miller RN, Walsh PC (1994) Concordance rates for benign prostatic disease among twins suggest hereditary influence. Urology 44:646–650

    PubMed  CAS  Google Scholar 

  158. Pientka L, van Loghem J, Hahn E, Keil U (1991) Häufigkeit und Komplikationen der Prostataadenomchirurgie bei Patienten mit benigner Prostatahyperplasie. Urologe B 31: 211–216

    Google Scholar 

  159. Powell PH, Smith PJB, Feneley RCL (1980) The identification of patients at risk from acute retention. Br J Urol 52: 520–522

    PubMed  CAS  Google Scholar 

  160. Quirinia A, Hoffmann AL (1993) Bladder diverticula in patients with prostatism. Int Urol Nephrol 25:243–247

    PubMed  CAS  Google Scholar 

  161. Reynard J, Lim C, Abrams P (1996) Significance of intermittency in men with lower urinary tract symptoms. Urology 47/4:491–496

    Google Scholar 

  162. Reynard JM, Lim C, Peters TJ, Abrams P (1996) The significance of terminal dribbling in men with lower urinary tract symptoms. Br J Urol 77: 705–710

    PubMed  CAS  Google Scholar 

  163. Riley G, Lubitz J (1986) Outcomes of surgery in the medicare aged population: rehospitalization after surgery. Health Care Financ Rev 8:23–34

    PubMed  CAS  Google Scholar 

  164. Roberts RO, Jacobsen SJ, Rhodes T et al. (1994) Cigarette smoking and prostatism: a biphasic association? Urology 43:797–801

    PubMed  CAS  Google Scholar 

  165. Roberts RO, Rhodes T, Panser LA et al. (1994) Natural history of prostatism: worry and embarrassment from urinary symptoms and health care-seeking behavior. Urology 43:621–628

    PubMed  CAS  Google Scholar 

  166. Roberts RO, Rhodes T, Panser LA et al. (1995) Association between family history prostatic hyperplasia and urinary symptoms: results of a population-based study. Am J Epidemiol 142: 965–973

    PubMed  CAS  Google Scholar 

  167. Roehrborn CG (1994) The assessment of patient complaints. Prog Clin Biol Res 386: 73–96

    PubMed  CAS  Google Scholar 

  168. Roos LL, Cageorge SM, Austen E, Lohr KN (1985) Using Computers to identify complications after surgery. Am J Public Health 75:1288–1295

    PubMed  Google Scholar 

  169. Roos LL, Cageorge SM, Roos NP, Danzinger R (1986) Centralization, certification, and monitoring Readmissions and complications after surgery. Med Care 24:1044–1066

    PubMed  Google Scholar 

  170. Roos NP, Ramsey EW (1987) A population-based study of prostatectomy: outcomes associated with different surgical approaches. J Urol 137:1184–1188

    PubMed  CAS  Google Scholar 

  171. Roos NP, Wennberg JE, Malenka DJ et al. (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320:1120–1124

    PubMed  CAS  Google Scholar 

  172. Russell EBAW, Lee AJ, Garraway WM, Prescott RJ (1994) Use of a 7-day diary for urinary Symptom recording. Eur Urol 26: 227–232

    PubMed  CAS  Google Scholar 

  173. Rutkow IM (1986) Urological Operations in the United States: 1979 to 1984. J Urol 135:1206–1208

    PubMed  CAS  Google Scholar 

  174. Ruud Bosch JLH (1995) Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia. World J Urol 13:17–20

    PubMed  CAS  Google Scholar 

  175. Sacks SH, Aparicio SAJR, Bevan A, Oliver DO, Will EJ, Davison AM (1989) Late renal failure due to prostatic outflow obstruction: a preventable disease. Br Med J 298:156–159

    CAS  Google Scholar 

  176. Sagnier PP, MacFarlane G, Richard F, Botto H, Teillac P, Boyle P (1994) Results of an epidemiological survey using a modified American Urological Association Symptom Index for benign prostatic hyperplasia in France. J Urol 151:1266–1270

    PubMed  CAS  Google Scholar 

  177. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P (1995) Impact of symptoms of prostatism on level of bother and quality of life of men in the French Community. J Urol 153: 669–673

    PubMed  CAS  Google Scholar 

  178. Sagnier PP, Girman CJ, Garaway M et al. (1996) International comparison on the Community prevalence of symptoms of prostatism in four countries. Eur Urol 29/1:15–20

    Google Scholar 

  179. Sanda MG, Beaty TH, Stutzman RE, Childs B, Walsh PC (1994) Genetic susceptibility of benign prostatic hyperplasia. J Urol 152: 115–119

    PubMed  CAS  Google Scholar 

  180. Schou J, Poulsen AL, Nordling J (1994) The anatomy of a prostate waiting list: a prospective study of 132 consecutive patients. Br J Urol 74: 57–60

    PubMed  CAS  Google Scholar 

  181. Seitter WR, Barrett-Connor E (1992) Cigarette smoking, obesity and benign prostatic hypertrophy: a prospective population-based study. Am J Epidemiol 135: 500–503

    PubMed  CAS  Google Scholar 

  182. Sejr T, Andersen TF, Madsen M, Roepstorff C, Bilde T, Bay-Nielsen H, Blais R, Holst E (1991) Prostatectomy in Denmark. Scand J Urol Nephrol 25:101–106

    PubMed  CAS  Google Scholar 

  183. Sidney S, Quesenberra Jr C, Sadler MC, Lydick EG, Guess HA, Cattolica EV (1991) Risk factors for surgically treated BPH in a prepared health care plan. Urology 38 [Suppl 1]: 13–19.

    Google Scholar 

  184. Sidney S, Quesenberry CP, Sadler MC, Cattolica EV, Lydick EG, Guess HA (1992) Reoperation and mortality after surgical treatment of benign prostatic hyperplasia in a large prepaid Med Care program. Med Care 30:117–125

    PubMed  CAS  Google Scholar 

  185. Simpson RJ, Lee RJ, Garraway WM, King D, Mclntosh I (1994) Consultation patterns in a Community survey of men with benign prostatic hyperplasia. Br J Gen Pract 44: 499–502

    PubMed  CAS  Google Scholar 

  186. Simpson RJ, Fisher W, Lee AJ, Russell EBAW, Garraway M (1996) Benign prostatic hyperplasia in an unselected community-based population: A survey of urinary symptoms, bothersomeness and prostatic enlargement. Br J Urol 77:186–191

    PubMed  CAS  Google Scholar 

  187. Sommer P, Nielsen KK, Bauer T, Kristensen ES, Hermann GG, Steven K, Nordling J (1990) Voiding patterns in men evaluated by a questionnaire survey. Br J Urol 65: 155–160

    PubMed  CAS  Google Scholar 

  188. Stephenson WP (1991) Incidence and outcome of surgery for BPH among residents of Rochester, Minnesota: 1980-87, a population based study. Urology 38 [Suppl 1]: 32–42

    PubMed  CAS  Google Scholar 

  189. Styles RA, Neal DE, Griffiths CJ, Ramsden PD (1988) Long-term monitoring of bladder pressure in chronic retention of urine: the relationship between detrusor activity and Upper tract dilatation. J Urol 140: 330–334

    PubMed  CAS  Google Scholar 

  190. Styles RA, Ramsden PD, Neal DE (1986) Chronic retention of urine. The relationship between Upper tract dilatation and bladder pressure. Br J Urol 58: 647–651

    PubMed  CAS  Google Scholar 

  191. Su L, Guess HA, Girman CJ, Jacobsen SJ, Oesterling JE, Panser LA, Lieber MM (1996) Adverse effects of medications on urinary symptoms and flow rate: a community-based study. J Clin Epidemiol 49: 483–487

    PubMed  CAS  Google Scholar 

  192. Taube M, Gajraj H (1989) Trial without catheter following acute retention of urine. Br J Urol 63: 180–182

    PubMed  CAS  Google Scholar 

  193. Taylor Z, Kraukauer H (1991) Mortality and reoperation following prostatectomy: outcomes in a medicare population. Urology 38 [Suppl 1]: 27–31

    PubMed  CAS  Google Scholar 

  194. Teboul F (1991) Descriptive analysis of a series of Operations for prostatic adenomas in inhabitants of Lyon, France, in 1988. Eur Urol 20 [Suppl 2): 18-21

    Google Scholar 

  195. Terris MK, Stamey TA (1991) Determination of prostate volume by transrectal ultrasound. J Urol 145: 984–987

    PubMed  CAS  Google Scholar 

  196. Tsang KK, Garraway WM (1993) Impact of benign prostatic hyperplasia on general well-being of men. Prostate 23:1–7

    PubMed  CAS  Google Scholar 

  197. Tsang KK, Garraway WM (1994). Prostatism and the bürden of benign prostatic hyperplasia on elderly men. Age Ageing 23: 360–364

    PubMed  CAS  Google Scholar 

  198. Tsukamoto T, Kumamoto Y, Masumori N et al. (1995) Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 154: 391–395

    PubMed  CAS  Google Scholar 

  199. Underbjerg-Poulsen E, Kirkeby HJ (1988) Home-monitoring of uroflow in normal male adoloscents relation between flow-curve, voided volume and time of day. Scand J Urol Nephrol 114: 58–62

    Google Scholar 

  200. Uson AC, Paez AB, Uson-Jaeger J (1991) The natural history and course of untreated benign prostatic hyperplasia. Eur Urol 20 [Suppl 2]: 22–26

    PubMed  Google Scholar 

  201. Vayda E, Mindell WR, Rutkow IM (1982) A decade of surgery in Canada England and Wales, and the United States. Arch Surg 117: 846–853

    PubMed  CAS  Google Scholar 

  202. Ward J, Sladden M (1994) Urinary symptoms in older men, their investigation and management: is there an epidemic of undetected morbidity in the waiting room? Fam Pract 11:251–259

    PubMed  CAS  Google Scholar 

  203. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG (1995) A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 332: 75–79

    PubMed  CAS  Google Scholar 

  204. Wennberg JE, Roos N, Sola L, Schori A, Jaffe R (1987) Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy. J Am Med Assoc 257: 933–936

    CAS  Google Scholar 

  205. Wennberg JE, Mulley AG jr, Hanley D et al. (1988) An assessment of prostatectomy for benign urinary tract obstruction. Geographie variations and the evaluation of medical care outcomes. J Am Med Assoc 259: 3027–3030

    CAS  Google Scholar 

  206. Wolfs GGMC, Knottnerus JA, Janknegt RA (1994) Prevalence and detection of micturition problems among 2.734 elderly men. J Urol 152:1467–1470

    PubMed  CAS  Google Scholar 

  207. Ziffren SE (1979) Comparison of mortality rates for various surgical Operations according to age groups, 1951-1977. J Am Geriatr Soc 27:433–438

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. L. Pientka
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Urologische Klinik, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

    Klaus Höfner , Udo Jonas  & Christian G. Stief ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pientka, L. (2000). Epidemiologie. In: Höfner, K., Jonas, U., Stief, C.G. (eds) Benigne Prostatahyperplasie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59580-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59580-6_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64034-6

  • Online ISBN: 978-3-642-59580-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation